Robert Li, Founder of LTZ Therapeutics

Robert Li is the founder of LTZ Therapeutics. LTZ Therapeutics has raised $130M in total funding. Latest round: Series A. Based in Palo Alto, California, US.

About Robert Li

Robert Li is the Founder and CEO of LTZ Therapeutics, a clinical-stage immunotherapy biotechnology company he co-founded in 2022. The company focuses on developing Universal Myeloid Cell Engager (U-MCE™) therapies for oncology and autoimmune diseases.

Robert Li at a glance

More founders in Palo Alto, California, US (44)

Browse related founder lists (4)

Full founder directory · Investor directory · Company funding database · Fundraising library